Aurobindo Pharma has divested stake in its Australian subsidiary to Eris Pharma for an undisclosed amount to focus on the US, European and emerging markets. The unit was not contributing any profit to Aurobindo Pharma.
Friday, 10 April 2015
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment